Notify me when STROME MEZZANINE FUND, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ZIVO | Zivo Bioscience, Inc. | Common Stock, par value $.001 per share | 12% | $53,142 | 442,854 | Mark E. Strome | 26 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|